Skip to content
‹ Back to IndustriesHealthcare

Is It Time to Revamp the Drug Development Pipeline?

Keypoints: Pharmaceutical industry is under pressure to increase demand and productivity. Pharma manufacturers are also expected to reduce waste in the drug development pipeline. Translational research is to get an idea to translate in a way to benefit the patient. Commentary: The pharmaceutical industry is undergoing a series of rapid changes. These days, there…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Keypoints:

  • Pharmaceutical industry is under pressure to increase demand and productivity.
  • Pharma manufacturers are also expected to reduce waste in the drug development pipeline.
  • Translational research is to get an idea to translate in a way to benefit the patient.

Commentary:

The pharmaceutical industry is undergoing a series of rapid changes. These days, there is higher demand, increased productivity, a race to get the drugs into consumers’ hands at a record pace, and a push to minimize waste in the process. MarketScale talked to Dr. Gabi Hanna, the CEO of Lamassu Pharma, to give his take on the drug development pipeline and what needs to be updated once the drug hits the market.

Abridged Thoughts:

In a basic and simple way, translational research is to take the idea from research and how to translate it into a tangible way to benefit the patient. This is the translation of knowledge to make a real impact on a patient. That is basically, in a nutshell, what does translational research is for us. 

More Like This Story:

What Can the Pharma Industry Learn from Merck’s New Antiviral?

MarketScale sourced Dr. Kishor M. Wasan, Chief Medical and Scientific Officer at Skymount Medical, for his perspective, pulling from his active research around drug production and AI. Scroll down for his various insights!

What is Behind the “Mergers & Acquisitions” Boom in Healthcare?

As the country continues to open and up and start on that path to recovery there has been a recent boom of healthcare mergers and acquisitions. On this upcoming episode of I Don’t Care, Kevin Stevenson speaks with the Co-Founders and Partners of M&A Healthcare Advisors, a boutique advisor firm whose focus is on the healthcare industry. The group talks about their plans to help small to middle sized businesses with M&As and how they hope to work with companies hands-on.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Ohio State–Microsoft partnership, reported at $250M, targets 70–80% shift to Azure

Ohio State–Microsoft partnership, reported at $250M, targets 70–80% shift to Azure

Ohio State University and Microsoft’s five-year partnership, reported by outlets at $250 million, is largely infrastructure: targeting a shift of roughly 70% to 80% of storage and computing to Azure and building a shared data layer. Note-drafting AI already runs. Smart-room features for patients come later and depend on that foundation.

  • 01The only part of the Ohio State and Microsoft deal with published results is AI note drafting, which saved up to four minutes per visit in Wexner's 2024 pilot.
  • 02Smart-room features such as automatic lighting and infection-risk alerts depend on a unified database that has finished only its high-level design. The first returns are more likely to show up in operating room and staffing forecasts.
  • 03Health systems weighing a similar platform deal should ask how the headline value breaks down, which workloads move first and whether the cloud copy of the EHR is a backup or the primary record.

Nov 14, 2026

Just 16% of AI-using healthcare organizations fully document model checks after launch, CHIME finds

Just 16% of AI-using healthcare organizations fully document model checks after launch, CHIME finds

CHIME's 2026 Digital Health Most Wired report finds 93.2% of surveyed healthcare organizations use AI. Full generative AI adoption nearly doubled in a year, to 54.8%. Oversight trails: only 16.4% of AI users fully document model monitoring after deployment, making governance the next job for hospital IT leaders.

  • 01Generative AI full adoption went from 31.0% to 54.8% of surveyed healthcare organizations in one year, while only 16.4% of AI users have fully documented processes for monitoring models after launch.
  • 02Organizations that test failover are about twice as likely to restore all critical systems within four hours (45.7% vs. 23.5%), suggesting regular drills may help close the gap.
  • 03Smaller organizations trail on prior authorization automation, 28.9% against 49.4% overall, and CMS payer API requirements take effect in January 2027.

Nov 14, 2026

Why MVP wants to push fresher care-gap data into EMRs

Why MVP wants to push fresher care-gap data into EMRs

MVP Health Care, a nonprofit insurer in New York and Vermont, built Arcadia-based provider dashboards that combine ADT alerts, care gaps, utilization and pharmacy data. Timing drives the design. Its next step, delivering care gaps inside provider EMRs, should move fastest with practices that already exchange data through Arcadia.

  • 01For a quality measure on a seven-day clock, a payer report that runs a few months behind arrives after the deadline it was meant to help with.
  • 02For MVP, the easiest EMR connections are with practices already exchanging data through Arcadia—such as Medicare ACOs using the platform or groups connected through other payers. Practices that are new to Arcadia or to payer data-sharing typically need more time and comfort with what they will send to MVP and what MVP will write back into their EMR.
  • 03A useful test for any payer’s provider analytics: does a service completed last week drop off the care-gap list, or does the practice still call the patient again?

Nov 13, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512